CGTX

Latest SEC Filings & News for CGTX

2 most recent filings and news items mentioning CGTX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CGTX/news?limit=20"

Pull CGTX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 4, 2026Positive

Cognition Therapeutics presents zervimesine advancement toward registrational development

Cognition Therapeutics presented investigational oral therapy zervimesine for DLB psychosis at Jefferies Global Healthcare Conference, advancing toward registrational clinical development. The company is progressing its lead candidate through clinical trials with expectations to

View filing at SEC.gov →

RegulatoryMay 21, 2026Positive

Cognition Therapeutics completes positive FDA meeting on zervimesine registrational program for DLB psychosis.

Cognition Therapeutics held a productive meeting with the FDA on May 20, 2026 to discuss Phase 2 results for zervimesine (CT1812) in dementia with Lewy bodies with psychosis and obtain guidance on advancing into late-stage trials. The positive discussion on the path forward is en

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.